HIV gp120 vaccine - ID Biomedical

Drug Profile

HIV gp120 vaccine - ID Biomedical

Alternative Names: gp 120 V3 loop peptide vaccine - ID Biomedical; HIV gp120 peptide vaccine - ID Biomedical; HIV-1 gp 120 V3 loop peptide vaccine - ID Biomedical; PND-PPD; V3 loop peptide vaccine - ID Biomedical

Latest Information Update: 30 Sep 2001

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Albert Einstein College of Medicine
  • Class AIDS vaccines
  • Mechanism of Action Immunomodulators; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV-1 infections

Most Recent Events

  • 30 Sep 2001 Discontinued-I for HIV-1 infections in Israel (Unknown route)
  • 25 Jul 2000 A clinical study has been added to the Viral Infections therapeutic trials section
  • 07 Jul 1999 Phase-I clinical trials for HIV-1 infections in Israel (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top